FairValu
ABBOTT LABORATORIES

ABBOTT LABORATORIES

ABTNYSE
Medical Devices • Healthcare•abbott.com
Current Price
$104.890.00%
Market Cap
$181.50B
Shares Outstanding: 1.73B
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--
SummaryResearchChartsSEC Filings

Latest results at a glance

Insights from the latest company results and reports · filed 16 Jul 2026

  • Second-Quarter Earnings Exceed Expectations

    Reported adjusted diluted EPS of $1.31 per share for the quarter ended June 30, 2026, exceeded the same-quarter consensus estimate of $1.28 per share.

  • Full-Year Guidance Raised

    Abbott raised its full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to the previous range of $5.38 to $5.58.

  • Medical Devices Segment Expands

    Medical Devices revenue rose 10.9% year-over-year to $377.0 million, representing 3.0% of consolidated revenue for the period.

  • New Cancer Screening Launch

    [2026-09-30] Abbott launched SimpleScreen CRC in the US, an FDA-approved blood-based test for average-risk adults who decline traditional colorectal screening methods.

AI-generated · updated 1 Oct 2026View source filing

Company research evidence

Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.

Loading evidence…

Deep Dive Research

Source-linked company research for ABT

Revenue segmentation

Loading segment disclosures…